Alpha-1-antitrypsin deficiency

Organisational unit: Research group


The research group conducts research on the clinical course and risk of developing lung disease, liver disease and other diseases in alpha-1-antitrypsin deficiency (AAT deficiency). Some of the research is based on the Swedish National Register of individuals with severe alpha-1 antitrypsin deficiency (AAT). The research group also follows a unique cohort of individuals with severe and moderate AAT deficiency identified through neonatal screening between 1972-194. The cohort is the only group of deficient individuals in the world, identified at birth and followed up regularly throughout life.

Recent research outputs

Kjell Toren, Linus Schiöler, Anne Lindberg, Anders Andersson, Annelie F. Behndig, Göran Bergström, Anders Blomberg, Kenneth Caidahl, Jan Engvall, Maria Eriksson, Viktor Hamrefors, Christer Janson, David Kylhammar, Eva Lindberg, Anders Lindén, Andrei Malinovschi, Hans Lennart Persson, Martin Sandelin, Jonas Eriksson Ström, Hanan A. Tanash & 4 others, Jenny Vikgren, Carl Johan Östgren, Per Wollmer & C. Magnus Sköld, 2020, In : BMJ Open Respiratory Research. 7, 1, e000600.

Research output: Contribution to journalArticle

View All (2)